Earth Science Tech, Inc. (OTC: ETST) has announced the acquisition of Meduvo LLC, a compounding pharmacy located in La Verne, California. This strategic move establishes a West Coast operational hub for the company and expands its pharmacy network to 34 U.S. jurisdictions, marking a significant step in its mission to build a vertically integrated healthcare platform.
Meduvo currently operates from a 2,000-square-foot facility, specializing in the compounding and dispensing of non-sterile medications. Earth Science Tech is already initiating facility upgrades designed to meet sterility requirements, with management targeting full regulatory certification for sterile compounding by the end of 2028. The company stated that regulatory approvals are pending in additional states as it pursues nationwide coverage.
This acquisition is part of Earth Science Tech’s broader strategy to integrate patient care from consultation to fulfillment. By combining compounding pharmacy operations with telemedicine platforms, clinical support, and direct-to-patient fulfillment, the company aims to create a seamless healthcare experience. The addition of Meduvo not only strengthens its geographic footprint but also enhances its capacity to serve patients across the country.
The importance of this acquisition lies in its potential to position Earth Science Tech as a major player in the compounding pharmacy market. With the expansion to 34 jurisdictions, the company can now reach a larger patient population, offering specialized medications that are often not available through standard pharmaceutical channels. The move also signals a commitment to high-quality care, as the planned upgrades to achieve sterile compounding certification will allow the company to offer a wider range of medications, including those that require sterile preparation.
For investors, this development underscores Earth Science Tech’s growth trajectory and its focus on building a robust healthcare network. The company’s diversified approach, which includes real estate and asset management, provides a stable foundation for its healthcare operations. As the company continues to expand its pharmacy network and pursue regulatory approvals, it is well-positioned to capitalize on the growing demand for personalized medicine.
The acquisition of Meduvo is a clear indicator of Earth Science Tech’s ambition to become a nationwide leader in the healthcare sector. By investing in facility upgrades and pursuing certifications, the company is not only expanding its reach but also enhancing its capabilities. This move is expected to have a positive impact on the company’s operational efficiency and revenue streams in the coming years.
For more details on the acquisition, interested parties can view the full press release at https://ibn.fm/wMvIu. Additionally, the latest news and updates relating to Earth Science Tech are available in the company’s newsroom at https://ibn.fm/ETST.
